Quantitative evaluation of safety in drug development : design, analysis and reporting

著者

    • Jiang, Qi (Biostatistician)
    • Xia, H. Amy

書誌事項

Quantitative evaluation of safety in drug development : design, analysis and reporting

edited by Qi Jiang, Amgen Inc, Thousand Oaks, California, USA, H. Amy Xia, Amgen Inc, Thousand Oaks, California, USA

(Chapman & Hall/CRC biostatistics series)

CRC Press/Taylor & Francis Group, c2015

この図書・雑誌をさがす

注記

Includes bibliographical references and index

[16] p. of colored plates between p. [172] and p. 173

内容説明・目次

内容説明

State-of-the-Art Methods for Drug Safety Assessment Responding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and observational studies in biopharmaceutical product development. It presents the latest statistical methods for drug safety assessment. The book's three sections focus on study design, safety monitoring, and data evaluation/analysis. The book addresses key challenges across regulatory agencies, industry, and academia. It discusses quantitative approaches to safety evaluation and risk management in drug development, covering Bayesian methods, effective safety graphics, and risk-benefit evaluation. Written by a team of experienced leaders, this book brings the most advanced knowledge and statistical methods of drug safety to the statistical, clinical, and safety community. It shares best practices and stimulates further research and methodology development in the drug safety area.

目次

Study Design. Safety Monitoring. Evaluation/Analysis. Index.

「Nielsen BookData」 より

関連文献: 1件中  1-1を表示

詳細情報

ページトップへ